Association between vascular comorbidity and progression of Alzheimer's disease: a two-year observational study in Norwegian memory clinics
- PMID: 29788900
- PMCID: PMC5964736
- DOI: 10.1186/s12877-018-0813-4
Association between vascular comorbidity and progression of Alzheimer's disease: a two-year observational study in Norwegian memory clinics
Abstract
Background: Vascular risk factors increase the risk of Alzheimer's disease (AD), but there is limited evidence on whether comorbid vascular conditions and risk factors have an impact on disease progression. The aim of this study was to examine the association between vascular disease and vascular risk factors and progression of AD.
Methods: In a longitudinal observational study in three Norwegian memory clinics, 282 AD patients (mean age 73.3 years, 54% female) were followed for mean 24 (16-37) months. Vascular risk factors and vascular diseases were registered at baseline, and the vascular burden was estimated by the Framingham Stroke Risk Profile (FSRP). Cerebral medical resonance images (MRIs) were assessed for white matter hyperintensities (WMH), lacunar and cortical infarcts. The associations between vascular comorbidity and progression of dementia as measured by annual change in Clinical Dementia Rating Sum of Boxes (CDR-SB) scores were analysed by multiple regression analyses, adjusted for age and sex.
Results: Hypertension occurred in 83%, hypercholesterolemia in 53%, diabetes in 9%, 41% were overweight, and 10% were smokers. One third had a history of vascular disease; 16% had heart disease and 15% had experienced a cerebrovascular event. MRI showed lacunar infarcts in 16%, WMH with Fazekas score 2 in 26%, and Fazekas score 3 in 33%. Neither the vascular risk factors and diseases, the FSRP score, nor cerebrovascular disease was associated with disease progression in AD.
Conclusions: Although vascular risk factors and vascular diseases were prevalent, no impact on the progression of AD after 2 years was shown.
Keywords: Alzheimer’s disease; Cardiovascular disease; Cardiovascular risk; Cognitive decline; Dementia; Mild cognitive impairment; Prognosis; Progression; Vascular risk factors.
Conflict of interest statement
Ethics approval and consent to participate
The Regional Committee for Medical and Health Research Ethics for South East Norway approved the study (REC number 2011/531). Patients underwent comprehensive cognitive testing at baseline, and only those who were found to have sufficient cognitive capacity to provide their own consent were invited to participate in the study. All patients gave written, informed consent for their participation in the study and for their clinical data to be used for research purposes. Patients who were not able to give informed consent at baseline were not included.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Similar articles
-
Progression of Alzheimer's Disease: A Longitudinal Study in Norwegian Memory Clinics.J Alzheimers Dis. 2018;61(3):1221-1232. doi: 10.3233/JAD-170436. J Alzheimers Dis. 2018. PMID: 29254085
-
Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia.J Alzheimers Dis. 2017;56(2):575-584. doi: 10.3233/JAD-160847. J Alzheimers Dis. 2017. PMID: 28035932
-
Small Vessel Cerebrovascular Pathology Identified by Magnetic Resonance Imaging Is Prevalent in Alzheimer's Disease and Mild Cognitive Impairment: A Potential Target for Intervention.J Alzheimers Dis. 2018;65(1):293-302. doi: 10.3233/JAD-180366. J Alzheimers Dis. 2018. PMID: 30040728
-
Vascular risk factors and Alzheimer's disease.Expert Rev Neurother. 2008 May;8(5):743-50. doi: 10.1586/14737175.8.5.743. Expert Rev Neurother. 2008. PMID: 18457531 Review.
-
White matter hyperintensities as early and independent predictors of Alzheimer's disease risk.J Alzheimers Dis. 2014;42 Suppl 4:S393-400. doi: 10.3233/JAD-141473. J Alzheimers Dis. 2014. PMID: 25261452 Review.
Cited by
-
Neuroimaging cerebrovascular biomarkers in Parkinson's disease.Neuroradiol J. 2022 Aug;35(4):490-496. doi: 10.1177/19714009211059118. Epub 2021 Dec 6. Neuroradiol J. 2022. PMID: 34872414 Free PMC article.
-
Baseline Profiles of Drug Prescriptions Prior to Diagnosis of Mild Cognitive Impairment (MCI) Obtained by Latent Class Analysis (LCA), and Assessment of Their Association with Conversion to Dementia.Healthcare (Basel). 2023 Aug 7;11(15):2219. doi: 10.3390/healthcare11152219. Healthcare (Basel). 2023. PMID: 37570459 Free PMC article.
-
Dysautonomia in Alzheimer's Disease.Medicina (Kaunas). 2020 Jul 8;56(7):337. doi: 10.3390/medicina56070337. Medicina (Kaunas). 2020. PMID: 32650427 Free PMC article. Review.
-
Promoting the Assessment of Physical Activity and Cardiorespiratory Fitness in Assessing the Role of Vascular Risk on Cognitive Decline in Older Adults.Front Physiol. 2019 May 31;10:670. doi: 10.3389/fphys.2019.00670. eCollection 2019. Front Physiol. 2019. PMID: 31214046 Free PMC article. No abstract available.
-
Association of total pre-existing comorbidities with stroke risk: a large-scale community-based cohort study from China.BMC Public Health. 2021 Oct 21;21(1):1910. doi: 10.1186/s12889-021-12002-1. BMC Public Health. 2021. PMID: 34674693 Free PMC article.
References
-
- Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, Ballard C, Banerjee S, Burns A, Cohen-Mansfield J, et al. Dementia prevention, intervention, and care. Lancet. 2017; - PubMed
-
- Petrovitch H, White LR, Izmirilian G, Ross GW, Havlik RJ, Markesbery W, Nelson J, Davis DG, Hardman J, Foley DJ, et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study. Neurobiol Aging. 2000;21(1):57–62. doi: 10.1016/S0197-4580(00)00106-8. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical